TipRanks
Go Ultimate55% OFF

Alethia Young Insider Profile

4 Followers

Alethia Young, Director at Pacira Pharmaceuticals, holds 17.80K shares in Pacira Pharmaceuticals (Ticker: PCRX), holds 21.07K shares in PTC Therapeutics (Ticker: PTCT), holds 87.08K shares in Bicycle Therapeutics (Ticker: BCYC).

Alethia Young's Trading History

PCRX
Pacira Pharmaceuticals
Jun 12, 2026DirectorUninformative Buy―$647.67K
BCYC
Bicycle Therapeutics
Jan 06, 2026CFOUninformative Sell12.28K$318.72K
PTCT
PTC Therapeutics
Jan 06, 2026DirectorUninformative Buy―$1.26M
LENZ
LENZ Therapeutics
―CFO――

You May Also Like

Alethia Young insider profile FAQ

What is the percentage of profitable transactions made by Alethia Young?
The percentage of profitable transactions made by Alethia Young is 100%.
What is the average return per transaction made by Alethia Young?
The average return per transaction made by Alethia Young is 40.40%.
What stocks does Alethia Young hold?
Alethia Young holds: PCRX, PTCT, BCYC, LENZ stocks.
What was Alethia Young's most profitable transaction?
Alethia Young’s most profitable transaction was an Informative Sell of BCYC stock on January 6, 2025. The return on the trade was 55.80%.
What is Alethia Young's role in Pacira Pharmaceuticals?
Alethia Young's role in Pacira Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.